| Year |
Citation |
Score |
| 2020 |
Miclea A, Bagnoud M, Chan A, Hoepner R. A Brief Review of the Effects of Vitamin D on Multiple Sclerosis. Frontiers in Immunology. 11: 781. PMID 32435244 DOI: 10.3389/Fimmu.2020.00781 |
0.315 |
|
| 2019 |
Gnant M, Martin M, Holmes F, Jackisch C, Chia S, Iwata H, Moy B, Martinez N, Mansi J, Morales S, Ruiz-Borrego M, Minckwitz Gv, Buyse M, Delaloge S, Bhandari M, ... ... Chan A, et al. Abstract P2-13-01: Efficacy of neratinib in hormone receptor-positive patients who initiated treatment within 1 year of completing trastuzumab-based adjuvant therapy in HER2+ early-stage breast cancer: Subgroup analyses from the phase III ExteNET trial Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P2-13-01 |
0.306 |
|
| 2018 |
Miclea A, Salmen A, Zoehner G, Diem L, Kamm CP, Chaloulos-Iakovidis P, Miclea M, Briner M, Kilidireas K, Stefanis L, Chan A, Evangelopoulos ME, Hoepner R. Age-dependent variation of female preponderance across different phenotypes of multiple sclerosis: A retrospective cross-sectional study. Cns Neuroscience & Therapeutics. PMID 30411534 DOI: 10.1111/Cns.13083 |
0.306 |
|
| 2018 |
Wagner F, Grunder L, Hakim A, Kamber N, Horn MP, Muellner J, Hoepner R, Wiest R, Metz I, Chan A, Salmen A. Rebound After Fingolimod and a Single Daclizumab Injection in a Patient Retrospectively Diagnosed With NMO Spectrum Disorder-MRI Apparent Diffusion Coefficient Maps in Differential Diagnosis of Demyelinating CNS Disorders. Frontiers in Neurology. 9: 782. PMID 30319524 DOI: 10.3389/Fneur.2018.00782 |
0.322 |
|
| 2018 |
Chia S, Martin M, Iwata H, Moy B, Lalani A, Holmes F, Mansi J, Minckwitz Gv, Buyse M, Delaloge S, Ejlertsen B, Yao B, Rosales AM, Hellerstedt B, Cold S, ... ... Chan A, et al. Abstract P1-13-03: Effects of neratinib after trastuzumab-based adjuvant therapy in hormone receptor-positive HER2+ early-stage breast cancer: Exploratory analyses from the phase III ExteNET trial Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P1-13-03 |
0.308 |
|
| 2018 |
de Stefano N, Achiron A, Barkhof F, Chan A, Derfuss T, Hodgkinson S, Leocani L, Montalban X, Prat A, Schmierer K, Sellebjerg F, Vermersch P, Wiendl H, Keller B, Roy S. THUR 174 The magnify-ms study: mavenclad® tablets in active rms Journal of Neurology, Neurosurgery & Psychiatry. 89: A23.1-A23. DOI: 10.1136/Jnnp-2018-Abn.81 |
0.319 |
|
| 2017 |
Rummel C, Aschwanden F, McKinley R, Wagner F, Salmen A, Chan A, Wiest R. A Fully Automated Pipeline for Normative Atrophy in Patients with Neurodegenerative Disease. Frontiers in Neurology. 8: 727. PMID 29416523 DOI: 10.3389/Fneur.2017.00727 |
0.312 |
|
| 2016 |
Fox RJ, Chan A, Zhang A, Xiao J, Levison D, Lewin JB, Edwards MR, Marantz JL. Comparative effectiveness using a matching-adjusted indirect comparison between delayed-release dimethyl fumarate and fingolimod for the treatment of multiple sclerosis. Current Medical Research and Opinion. 1-23. PMID 27733070 DOI: 10.1080/03007995.2016.1248380 |
0.315 |
|
| 2016 |
Hoepner R, Kolb EM, Dahlhaus S, Hellwig K, Adams O, Kleiter I, Salmen A, Schneider R, Lukas C, Chan A, Berger JR, Gold R. Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 27600113 DOI: 10.1177/1352458516667241 |
0.31 |
|
| 2016 |
Andlauer TF, Buck D, Antony G, Bayas A, Bechmann L, Berthele A, Chan A, Gasperi C, Gold R, Graetz C, Haas J, Hecker M, Infante-Duarte C, Knop M, Kümpfel T, et al. Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation. Science Advances. 2: e1501678. PMID 27386562 DOI: 10.1126/Sciadv.1501678 |
0.314 |
|
| 2016 |
Sehr T, Proschmann U, Thomas K, Marggraf M, Straube E, Reichmann H, Chan A, Ziemssen T. New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies. Journal of Neuroinflammation. 13: 164. PMID 27349895 DOI: 10.1186/S12974-016-0635-2 |
0.344 |
|
| 2016 |
Sadovnick AD, Traboulsee AL, Bernales CQ, Ross JP, Forwell AL, Yee IM, Guillot-Noel L, Fontaine B, Cournu-Rebeix I, Alcina A, Fedetz M, Izquierdo G, Matesanz F, Hilven K, Dubois B, ... ... Chan A, et al. Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients. G3 (Bethesda, Md.). PMID 27194806 DOI: 10.1534/G3.116.030841 |
0.357 |
|
| 2016 |
Klotz L, Berthele A, Brück W, Chan A, Flachenecker P, Gold R, Haghikia A, Hellwig K, Hemmer B, Hohlfeld R, Korn T, Kümpfel T, Lang M, Limmroth V, Linker RA, et al. [Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action]. Der Nervenarzt. PMID 26927677 DOI: 10.1007/S00115-016-0077-1 |
0.324 |
|
| 2015 |
Schrewe L, Lill CM, Liu T, Salmen A, Gerdes LA, Guillot-Noel L, Akkad DA, Blaschke P, Graetz C, Hoffjan S, Kroner A, Demir S, Böhme A, Rieckmann P, ElAli A, ... ... Chan A, et al. Investigation of sex-specific effects of apolipoprotein E on severity of EAE and MS. Journal of Neuroinflammation. 12: 234. PMID 26669675 DOI: 10.1186/S12974-015-0429-Y |
0.321 |
|
| 2015 |
Kohlmann R, Salmen A, Chan A, Knabbe C, Diekmann J, Brockmeyer N, Skaletz-Rorowski A, Michalik C, Gold R, Überla K. Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 25828755 DOI: 10.1177/1352458515576984 |
0.334 |
|
| 2015 |
Hoffjan S, Okur A, Epplen JT, Wieczorek S, Chan A, Akkad DA. Association of TNFAIP3 and TNFRSF1A variation with multiple sclerosis in a German case-control cohort. International Journal of Immunogenetics. 42: 106-10. PMID 25684197 DOI: 10.1111/Iji.12183 |
0.32 |
|
| 2015 |
Hoepner R, Klotz P, Faissner S, Schneider R, Kinner M, Prehn C, Gold R, Chan A. Neuropsychological impairment in natalizumab-associated progressive multifocal leukoencephalopathy: implications for early diagnosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 25628377 DOI: 10.1136/Jnnp-2014-310287 |
0.33 |
|
| 2015 |
Grey Née Cotte S, Salmen Née Stroet A, von Ahsen N, Starck M, Winkelmann A, Zettl UK, Comabella M, Montalban X, Zipp F, Fleischer V, Kruse N, Gold R, Chan A. Lack of efficacy of mitoxantrone in primary progressive Multiple Sclerosis irrespective of pharmacogenetic factors: a multi-center, retrospective analysis. Journal of Neuroimmunology. 278: 277-9. PMID 25468777 DOI: 10.1016/J.Jneuroim.2014.11.017 |
0.353 |
|
| 2014 |
Strassburger-Krogias K, Ellrichmann G, Krogias C, Altmeyer P, Chan A, Gold R. Fumarate treatment in progressive forms of multiple sclerosis: first results of a single-center observational study. Therapeutic Advances in Neurological Disorders. 7: 232-8. PMID 25342977 DOI: 10.1177/1756285614544466 |
0.338 |
|
| 2014 |
Fleischer V, Salmen A, Kollar S, Weyer V, Siffrin V, Chan A, Zipp F, Luessi F. Cardiotoxicity of mitoxantrone treatment in a german cohort of 639 multiple sclerosis patients. Journal of Clinical Neurology (Seoul, Korea). 10: 289-95. PMID 25324877 DOI: 10.3988/Jcn.2014.10.4.289 |
0.332 |
|
| 2014 |
Varzari A, Bruch K, Deyneko IV, Chan A, Epplen JT, Hoffjan S. Analysis of polymorphisms in RIG-I-like receptor genes in German multiple sclerosis patients. Journal of Neuroimmunology. 277: 140-4. PMID 25288302 DOI: 10.1016/J.Jneuroim.2014.09.015 |
0.314 |
|
| 2014 |
Hoepner R, Ahlbrecht J, Faissner S, Schneider R, Dahlhaus S, Adams O, Raab P, Lukas C, Chan A, Stangel M, Gold R. Clinical and paraclinical findings in natalizumab-associated infratentorial progressive multifocal leukoencephalopathy patients. Journal of Neurology, Neurosurgery, and Psychiatry. 85: 1177-8. PMID 24700881 DOI: 10.1136/Jnnp-2014-307582 |
0.333 |
|
| 2014 |
Tsivgoulis G, Sergentanis TN, Chan A, Voumvourakis K, Triantafyllou N, Psaltopoulou T, Gold R, Krogias C. Chronic cerebrospinal venous insufficiency and multiple sclerosis: a comprehensive meta-analysis of case-control studies. Therapeutic Advances in Neurological Disorders. 7: 114-36. PMID 24587827 DOI: 10.1177/1756285613499425 |
0.322 |
|
| 2014 |
Salmen A, Gold R, Chan A. Management of disease-modifying treatments in neurological autoimmune diseases of the central nervous system. Clinical and Experimental Immunology. 176: 135-48. PMID 24358961 DOI: 10.1111/Cei.12258 |
0.375 |
|
| 2013 |
Schwab N, Schneider-Hohendorf T, Posevitz V, Breuer J, Göbel K, Windhagen S, Brochet B, Vermersch P, Lebrun-Frenay C, Posevitz-Fejfár A, Capra R, Imberti L, Straeten V, Haas J, Wildemann B, ... ... Chan A, et al. L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients. Neurology. 81: 865-71. PMID 23925765 DOI: 10.1212/Wnl.0B013E3182A351Fb |
0.344 |
|
| 2013 |
Stroet A, Trampe N, Chan A. Treatment failure of intrathecal baclofen and supra-additive effect of nabiximols in multiple sclerosis-related spasticity: a case report: Therapeutic Advances in Neurological Disorders. 6: 199-203. PMID 23634192 DOI: 10.1177/1756285613475835 |
0.333 |
|
| 2013 |
Dahlhaus S, Hoepner R, Chan A, Kleiter I, Adams O, Lukas C, Hellwig K, Gold R. Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients. Journal of Neurology, Neurosurgery, and Psychiatry. 84: 1068-74. PMID 23606731 DOI: 10.1136/Jnnp-2013-304897 |
0.343 |
|
| 2013 |
Chan A, Lo-Coco F. Mitoxantrone-related acute leukemia in MS An open or closed book? Neurology. 80: 1529-1533. PMID 23589639 DOI: 10.1212/Wnl.0B013E31828Cf891 |
0.333 |
|
| 2013 |
Ayzenberg I, Kleiter I, Schröder A, Hellwig K, Chan A, Yamamura T, Gold R. Interleukin 6 receptor blockade in patients with neuromyelitis optica nonresponsive to anti-CD20 therapy. Jama Neurology. 70: 394-7. PMID 23358868 DOI: 10.1001/Jamaneurol.2013.1246 |
0.301 |
|
| 2013 |
Lill CM, Schjeide BM, Graetz C, Liu T, Damotte V, Akkad DA, Blaschke P, Gerdes LA, Kroner A, Luessi F, Cournu-Rebeix I, Hoffjan S, Winkelmann A, Touze E, Pico F, ... ... Chan A, et al. Genome-wide significant association of ANKRD55 rs6859219 and multiple sclerosis risk. Journal of Medical Genetics. 50: 140-3. PMID 23315543 DOI: 10.1136/Jmedgenet-2012-101411 |
0.346 |
|
| 2013 |
Harrer A, Tumani H, Niendorf S, Lauda F, Geis C, Weishaupt A, Kleinschnitz C, Rauer S, Kuhle J, Stangel M, Weber F, Uhr M, Linnebank M, Wildemann B, Jarius S, ... ... Chan A, et al. Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 1209-12. PMID 23093485 DOI: 10.1177/1352458512463483 |
0.347 |
|
| 2013 |
Décard BF, Haghikia A, Tönnes C, Thöne J, Lukas C, Chan A, Gold R. Natalizumab-associated reversible encephalopathy syndrome mimicking progressive multifocal leukoencephalopathy. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 249-51. PMID 22596228 DOI: 10.1177/1352458512448268 |
0.314 |
|
| 2013 |
Burek M, Haghikia A, Gold R, Roewer N, Chan A, Frster CY. Differential Cytokine Release from Brain Microvascular Endothelial Cells Treated with Dexamethasone and Multiple Sclerosis Patient Sera Journal of Steroids & Hormonal Science. 5: 1-8. DOI: 10.4172/2157-7536.1000128 |
0.336 |
|
| 2013 |
Chan A, Walter U, Kallmann B, Wernsdoerfer C, Zingler VC. Monitoring and management of MS patients starting natalizumab therapy in Germany — /INS;Final results of the prospective TYSTART study Journal of the Neurological Sciences. 333. DOI: 10.1016/J.Jns.2013.07.1386 |
0.315 |
|
| 2012 |
Lill CM, Liu T, Schjeide BM, Roehr JT, Akkad DA, Damotte V, Alcina A, Ortiz MA, Arroyo R, Lopez de Lapuente A, Blaschke P, Winkelmann A, Gerdes LA, Luessi F, Fernadez O, ... ... Chan A, et al. Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects. Journal of Medical Genetics. 49: 558-62. PMID 22972946 DOI: 10.1136/Jmedgenet-2012-101175 |
0.303 |
|
| 2012 |
Décard BF, von Ahsen N, Grunwald T, Streit F, Stroet A, Niggemeier P, Schottstedt V, Riggert J, Gold R, Chan A. Low vitamin D and elevated immunoreactivity against Epstein-Barr virus before first clinical manifestation of multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 83: 1170-3. PMID 22888143 DOI: 10.1136/Jnnp-2012-303068 |
0.301 |
|
| 2012 |
Srivastava R, Aslam M, Kalluri SR, Schirmer L, Buck D, Tackenberg B, Rothhammer V, Chan A, Gold R, Berthele A, Bennett JL, Korn T, Hemmer B. Potassium channel KIR4.1 as an immune target in multiple sclerosis. The New England Journal of Medicine. 367: 115-23. PMID 22784115 DOI: 10.1056/Nejmoa1110740 |
0.316 |
|
| 2012 |
Elliott C, Lindner M, Arthur A, Brennan K, Jarius S, Hussey J, Chan A, Stroet A, Olsson T, Willison H, Barnett SC, Meinl E, Linington C. Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis. Brain : a Journal of Neurology. 135: 1819-33. PMID 22561643 DOI: 10.1093/Brain/Aws105 |
0.319 |
|
| 2012 |
Stroet A, Hemmelmann C, Starck M, Zettl U, Dörr J, Friedemann P, Paul F, Flachenecker P, Fleischer V, Zipp F, Nückel H, Kieseier BC, Ziegler A, Gold R, Chan A. Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany. Therapeutic Advances in Neurological Disorders. 5: 75-9. PMID 22435072 DOI: 10.1177/1756285611433318 |
0.336 |
|
| 2012 |
Stroet A, Gold R, Chan A. Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone. Neurology. 78: 933; author reply 93. PMID 22431743 DOI: 10.1212/01.Wnl.0000413366.14351.54 |
0.3 |
|
| 2012 |
Lill CM, Schjeide BM, Akkad DA, Blaschke P, Winkelmann A, Gerdes LA, Hoffjan S, Luessi F, Dörner T, Li SC, Steinhagen-Thiessen E, Lindenberger U, Chan A, Hartung HP, Aktas O, et al. Independent replication of STAT3 association with multiple sclerosis risk in a large German case-control sample. Neurogenetics. 13: 83-6. PMID 22095036 DOI: 10.1007/S10048-011-0305-6 |
0.336 |
|
| 2011 |
Malhotra S, Morcillo-Suárez C, Brassat D, Goertsches R, Lechner-Scott J, Urcelay E, Fernández O, Drulovic J, García-Merino A, Boneschi FM, Chan A, Vandenbroeck K, Navarro A, Bustamante MF, Río J, et al. IL28B polymorphisms are not associated with the response to interferon-beta in multiple sclerosis Journal of Neuroimmunology. 239: 101-104. PMID 21889215 DOI: 10.1016/J.Jneuroim.2011.08.004 |
0.31 |
|
| 2011 |
Rey LK, Wieczorek S, Akkad DA, Linker RA, Chan A, Hoffjan S. Polymorphisms in genes encoding leptin, ghrelin and their receptors in German multiple sclerosis patients. Molecular and Cellular Probes. 25: 255-259. PMID 21664965 DOI: 10.1016/J.Mcp.2011.05.004 |
0.337 |
|
| 2011 |
Hellwig K, Schimrigk S, Chan A, Epplen J, Gold R. A newborn with Pierre Robin sequence after preconceptional mitoxantrone exposure of a female with multiple sclerosis. Journal of the Neurological Sciences. 307: 164-5. PMID 21601225 DOI: 10.1016/J.Jns.2011.05.003 |
0.305 |
|
| 2011 |
Haghikia A, Perrech M, Pula B, Ruhrmann S, Potthoff A, Brockmeyer NH, Goelz S, Wiendl H, Lindå H, Ziemssen T, Baranzini SE, Käll TB, Bengel D, Olsson T, Gold R, ... Chan A, et al. Functional energetics of CD4+-cellular immunity in monoclonal antibody-associated progressive multifocal leukoencephalopathy in autoimmune disorders. Plos One. 6: e18506. PMID 21533133 DOI: 10.1371/Journal.Pone.0018506 |
0.311 |
|
| 2011 |
Chan A, Artuso T, Krull UJ. Sample Handling Protocols for Biosensor Applications Handbook of Sample Preparation. 385-418. DOI: 10.1002/9780813823621.ch21 |
0.378 |
|
| 2010 |
Meyer C, Ansorge N, Siglienti I, Salmen S, Stroet A, Nückel H, Dührsen U, Ritter PR, Schmidt WE, Gold R, Chan A. [Mitoxantrone-related acute leukemia by multiple sclerosis. Case report and practical approach by unclear cytopenia]. Der Nervenarzt. 81: 1483-9. PMID 21079910 DOI: 10.1007/S00115-010-3041-5 |
0.334 |
|
| 2010 |
Chan A, Decard BF, Franke C, Grummel V, Zhou D, Schottstedt V, Toyka KV, Hemmer B, Gold R. Serum antibodies to conformational and linear epitopes of myelin oligodendrocyte glycoprotein are not elevated in the preclinical phase of multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 16: 1189-92. PMID 20685767 DOI: 10.1177/1352458510376406 |
0.306 |
|
| 2010 |
Stüve O, Kieseier BC, Hemmer B, Hartung HP, Awad A, Frohman EM, Greenberg BM, Racke MK, Zamvil SS, Phillips JT, Gold R, Chan A, Zettl U, Milo R, Marder E, et al. Translational research in neurology and neuroscience 2010: multiple sclerosis. Archives of Neurology. 67: 1307-15. PMID 20625066 DOI: 10.1001/Archneurol.2010.158 |
0.323 |
|
| 2010 |
Blecharz KG, Haghikia A, Stasiolek M, Kruse N, Drenckhahn D, Gold R, Roewer N, Chan A, Förster CY. Glucocorticoid effects on endothelial barrier function in the murine brain endothelial cell line cEND incubated with sera from patients with multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 16: 293-302. PMID 20203147 DOI: 10.1177/1352458509358189 |
0.305 |
|
| 2010 |
Steinberg SC, Faris RJ, Chang CF, Chan A, Tankersley MA. Impact of adherence to interferons in the treatment of multiple sclerosis: a non-experimental, retrospective, cohort study. Clinical Drug Investigation. 30: 89-100. PMID 20067327 DOI: 10.2165/11533330-000000000-00000 |
0.326 |
|
| 2009 |
Hellwig K, Beste C, Schimrigk S, Chan A. Immunomodulation and postpartum relapses in patients with multiple sclerosis. Therapeutic Advances in Neurological Disorders. 2: 7-11. PMID 21180639 DOI: 10.1177/1756285608100416 |
0.324 |
|
| 2009 |
Wenning W, Haghikia A, Laubenberger J, Clifford DB, Behrens PF, Chan A, Gold R. Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. The New England Journal of Medicine. 361: 1075-80. PMID 19741228 DOI: 10.1056/Nejmoa0810257 |
0.325 |
|
| 2009 |
Cotte S, Ahsen Nv, Kruse N, Huber B, Winkelmann A, Zettl UK, Starck M, König N, Tellez N, Dörr J, Paul F, Zipp F, Lühder F, Koepsell H, Pannek H, ... ... Chan A, et al. ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis Brain. 132: 2517-2530. PMID 19605531 DOI: 10.1093/Brain/Awp164 |
0.338 |
|
| 2009 |
Wieczorek S, Hoffjan S, Chan A, Rey L, Harper L, Fricke H, Holle JU, Gross WL, Epplen JT, Lamprecht P. Novel association of the CD226 (DNAM-1) Gly307Ser polymorphism in Wegener's granulomatosis and confirmation for multiple sclerosis in German patients Genes and Immunity. 10: 591-595. PMID 19536154 DOI: 10.1038/Gene.2009.44 |
0.346 |
|
| 2009 |
Schröder A, Fischer M, Meyer C, Ellrichmann G, Thöne J, Linker RA, Chan A, Gold R. Plasmapherese in der Eskalationstherapie der Multiplen Sklerose: Verlaufsbeobachtung an 35 Patienten Aktuelle Neurologie. 36: 105-110. DOI: 10.1055/S-0028-1090231 |
0.344 |
|
| 2008 |
Stüve O, Gold R, Chan A, Mix E, Zettl U, Kieseier BC. α4-Integrin antagonism with natalizumab Journal of Neurology. 255: 58-65. PMID 19300961 DOI: 10.1007/S00415-008-6011-0 |
0.314 |
|
| 2008 |
Chan A, Stüve O, Ahsen Nv. Immunosuppression in clinical practice: approaches to individualized therapy. Journal of Neurology. 255: 22-27. PMID 19300956 DOI: 10.1007/S00415-008-6005-Y |
0.33 |
|
| 2008 |
Haupts MR, Schimrigk SK, Brune N, Chan A, Ahle G, Hellwig K, König FB, Schlegel U, Brück W, Gold R. Fulminant tumefactive multiple sclerosis: Therapeutic implications of histopathology Journal of Neurology. 255: 1272-1273. PMID 18677644 DOI: 10.1007/S00415-008-0883-X |
0.311 |
|
| 2008 |
Haghikia A, Fischer M, Hellwig K, Linker R, Chan A, Hohlfeld R, Gold R. Open use of natalizumab. Neutralising antibodies and clinical data Nervenarzt. 79: 716-719. PMID 18437340 DOI: 10.1007/S00115-008-2464-8 |
0.334 |
|
| 2006 |
Chan A, Krull UJ. Capillary electrophoresis for capture and concentrating of target nucleic acids by affinity gels modified to contain single-stranded nucleic acid probes. Analytica Chimica Acta. 578: 31-42. PMID 17723692 DOI: 10.1016/J.Aca.2006.05.057 |
0.441 |
|
| 2006 |
Schilling S, Linker RA, König FB, Koziolek M, Bähr M, Müller GA, Paulus W, Gärtner J, Brück W, Chan A, Gold R. Plasmaaustausch bei steroidresistenten Multiple-Sklerose-Schüben Nervenarzt. 77: 430-438. PMID 16341736 DOI: 10.1007/S00115-005-2019-1 |
0.327 |
|
| 2006 |
Linker RA, Chan A. Neuartige Immuntherapien der Multiplen Sklerose (MS) Psychoneuro. 32: 149-154. DOI: 10.1055/S-2006-940246 |
0.343 |
|
| 2005 |
Chan A, Weilbach FX, Toyka KV, Gold R. Mitoxantrone induces cell death in peripheral blood leucocytes of multiple sclerosis patients Clinical and Experimental Immunology. 139: 152-158. PMID 15606626 DOI: 10.1111/J.1365-2249.2005.02653.X |
0.315 |
|
| 2004 |
Weilbach FX, Chan A, Toyka KV, Gold R. The cardioprotector dexrazoxane augments therapeutic efficacy of mitoxantrone in experimental autoimmune encephalomyelitis Clinical and Experimental Immunology. 135: 49-55. PMID 14678264 DOI: 10.1111/J.1365-2249.2004.02344.X |
0.327 |
|
| Show low-probability matches. |